Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Octyl triazone

This article was originally published in The Tan Sheet

Executive Summary

BASF asks for 90-day extension to respond to FDA's request for data on octyl triazone sunscreen; the previous deadline was Oct. 9. Firm maintains more time is needed to compile recent effectiveness data. Beiersdorf submitted a separate letter Oct. 7 in support of BASF's time and extent application, noting the German firm has used the ingredient in its own sun care products outside the U.S. for more than five years without "unusual adverse event experience." FDA requested safety data on octyl triazone and two other sunscreen ingredients in a July 11 Federal Register notice (1"The Tan Sheet" July 14, 2003, In Brief)...

You may also be interested in...



Sunscreen TEAs

FDA requests safety and efficacy data on three sunscreens based on its determination that time and extent applications indicate the ingredients are "eligible for consideration" for inclusion in OTC monograph, according to 1July 11 Federal Register notice. Data sought on amiloxate (isoamyl p-methoxycinnamate), enzacamene (methyl benzylidene camphor) and octyl triazone by Oct. 9. TEAs for ingredients were filed by Haarmann & Reimer, Merck KgaA and BASF AG, respectively. Agency will make a final decision on ingredients' status following review of submitted information...

Inovio Confirms Frontrunner Status In COVID-19 Vaccine Race, But Can It Prove Skeptics Wrong?

Its ‘virus chasing’ habits has given Inovio a bad reputation. But with backing from CEPI and Bill Gates, it has a chance to prove the doubters wrong.

Global Pharma Guidance Tracker – March 2020

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Topics

UsernamePublicRestriction

Register

PS096066

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel